P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d |
_version_ | 1797280805627625472 |
---|---|
author | David Ross Devendra Hiwase Steven Lane Kirsty Sharplin Agnes Yong Yeung David Dale Chappell Cameron Durrant Timothy Hughes Daniel Thomas |
author_facet | David Ross Devendra Hiwase Steven Lane Kirsty Sharplin Agnes Yong Yeung David Dale Chappell Cameron Durrant Timothy Hughes Daniel Thomas |
author_sort | David Ross |
collection | DOAJ |
first_indexed | 2024-03-07T16:46:28Z |
format | Article |
id | doaj.art-b02e569c1a13481b8355465a3fe13b10 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:46:28Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-b02e569c1a13481b8355465a3fe13b102024-03-03T06:25:17ZengWileyHemaSphere2572-92412023-08-017e231146d10.1097/01.HS9.0000969852.23114.6d202308003-00637P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIALDavid Ross0Devendra Hiwase1Steven Lane2Kirsty Sharplin3Agnes Yong4Yeung David5Dale Chappell6Cameron Durrant7Timothy Hughes8Daniel Thomas91 South Australian Health & Medical Research Institute, Adelaide, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia2 Queensland Institute of Medical Research, Brisbane, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia3 Royal Perth Hospital, Perth, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australia4 Humanigen, Inc, Short Hills, NJ, United States4 Humanigen, Inc, Short Hills, NJ, United States1 South Australian Health & Medical Research Institute, Adelaide, Australia1 South Australian Health & Medical Research Institute, Adelaide, Australiahttp://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d |
spellingShingle | David Ross Devendra Hiwase Steven Lane Kirsty Sharplin Agnes Yong Yeung David Dale Chappell Cameron Durrant Timothy Hughes Daniel Thomas P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL HemaSphere |
title | P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL |
title_full | P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL |
title_fullStr | P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL |
title_full_unstemmed | P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL |
title_short | P737: LENZILUMAB AND AZACITIDINE IMPROVE HEMATOLOGIC ALTERATIONS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE PREACH-M TRIAL |
title_sort | p737 lenzilumab and azacitidine improve hematologic alterations of chronic myelomonocytic leukemia in the preach m trial |
url | http://journals.lww.com/10.1097/01.HS9.0000969852.23114.6d |
work_keys_str_mv | AT davidross p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT devendrahiwase p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT stevenlane p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT kirstysharplin p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT agnesyong p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT yeungdavid p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT dalechappell p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT camerondurrant p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT timothyhughes p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial AT danielthomas p737lenzilumabandazacitidineimprovehematologicalterationsofchronicmyelomonocyticleukemiainthepreachmtrial |